SCHEMBL3249667

SCHEMBL3249667

Cc1cc(C)c(S(=O)(=O)NCC(=O)Nc2ccc(Cl)cc2C(O)c2ccccc2Cl)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 4/20 0.39
MAPT P10636 3/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEP1B Q16820 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
IDH1 O75874 1/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 2/20 0.36
BACE1 P56817 1/20 0.36
POLB P06746 1/20 0.36
PTGES O14684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4872762 0.95 LMNA (0.40) FDFT1MAPTALDH1A1LMNAMEN1
SCHEMBL3253080 0.91 FDFT1 (0.40) FDFT1MAPTALDH1A1LMNAMEN1
SCHEMBL3251156 0.89 FLT1 (0.42) FDFT1MAPTALDH1A1LMNAMEN1
SCHEMBL3249174 0.88 L3MBTL1 (0.44) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL3248909 0.86 LMNA (0.43) FDFT1MAPTALDH1A1LMNAMEN1
SCHEMBL3246435 0.85 ALDH1A1 (0.42) FDFT1MAPTALDH1A1LMNAMEN1
SCHEMBL3247544 0.85 ALDH1A1 (0.48) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL3251363 0.85 SMN1; SMN2 (0.43) FDFT1MAPTALDH1A1LMNAMEN1
SCHEMBL3246730 0.84 LPAR1 (0.44) FDFT1MAPTALDH1A1LMNAMEN1
SCHEMBL3244695 0.83 CYP1A2 (0.48) MAPTALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776347-B1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2010-05-26 EP disclosed
US-7396958-B2 Sulphonamide derivatives, their preparation and their therapeutic application SANOFI AVENTIS (FR) 2008-07-08 US disclosed
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HCRTR2, GIPR, SSTR2 FDFT1 1608/4885MAPT 3113/4885ALDH1A1 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.